º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Economic Development

BioGrad could be sold as it appoints Harrogate International Advisory to 'develop next strategic phase'

It comes after 18 months of 'unprecedented growth'

Dr Natalie Kenny of BioGrad Diagnostics(Image: Andrew Teebay/Liverpool Echo)

Liverpool Covid testing firm BioGrad Limited could be sold after it appointed a financial advisory firm "to develop its next strategic phase" following a period of "unprecedented" growth.

The Liverpool Science Park-based company, one of the º£½ÇÊÓÆµ's largest testing firms, has appointed Harrogate International Advisory - an organisation providing services in areas such as mergers and acquisitions, joint ventures, management buyouts and IPOs.

With its head office in Liverpool and sites in Bootle, Warrington and Manchester, BioGrad employs over 280 people, and is in line to record an EBITDA of over £10m this year.

READ MORE: B&M reports 'particularly encouraging' sales as retail giant 'well positioned' for Golden Quarter

Dr Natalie Kenny, founder and CEO of BioGrad, said: “The company is on a huge growth trajectory and has performed exceptionally well - we are considering options for the future direction of the business.

"We look forward to working with Harrogate International Advisors to help strategically develop the business as we enter into the next stage of our growth.”

Faisal Arif and Sue Wright have been appointed "to support the strategic development of the business and its ongoing growth".